Ideaya Biosciences (IDYA) PT Raised to $53 at RBC Capital

April 14, 2026 6:39 AM

RBC Capital analyst Leonid Timashev raised the price target on Ideaya Biosciences (NASDAQ: IDYA) to $53.00 (from $49.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found